The tyrosine kinase FES is an essential effector of KITD816V proliferation signal

被引:43
作者
Voisset, Edwige
Lopez, Sophie
Dubreuil, Patrice
De Sepulveda, Paulo
机构
[1] INSERM, UMR 599, Ctr Rech Cancerol, Lab Hematopoiese Mol & Fonctionnelle, F-13009 Marseille, France
[2] Inst Paoli Calmettes, Marseille, France
[3] Univ Mediterranee, Marseille, France
关键词
D O I
10.1182/blood-2007-02-076471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
KIT is a tyrosine kinase receptor that is aberrantly activated in several neoplasms. In human pathologies, the most frequent mutation of KIT occurs at codon 816. The resulting KIT mutant protein is activated in the absence of ligand and is resistant to the clinically available inhibitors of KIT. In this report, we provide evidence for an essential function of the cytoplasmic tyrosine kinase FES downstream of KITD816V. FES is phosphorylated on tyrosine residues in cells that carry KITD816V mutation, and this phosphorylation is KIT dependent. Reduction of FES expression using RNA interference results in decreased cell proliferation in human or murine cells harboring KITD816V or the homologous mouse mutation KITD814Y. The reduced cell growth can be rescued using another cytokine (granulocyte-macrophage colony-stimulating factor [GM-CSF]) and is not observed when the closely related fer gene is targeted. Finally, signaling downstream of KITD8161 is altered in cells lacking FES expression. This study shows a major function of FES downstream of activated KIT receptor and thereby points to FES as a novel target in KIT-related pathologies.
引用
收藏
页码:2593 / 2599
页数:7
相关论文
共 67 条
[1]   Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis:: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412 [J].
Aichberger, Karl J. ;
Mayerhofer, Matthias ;
Gleixner, Karoline V. ;
Krauth, Maria-Theresa ;
Gruze, Alexander ;
Pickl, Winfried F. ;
Wacheck, Volker ;
Selzer, Edgar ;
Muellauer, Leonhard ;
Agis, Hermine ;
Sillaber, Christian ;
Valent, Peter .
BLOOD, 2007, 109 (07) :3031-3041
[2]   Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit [J].
Akin, C ;
Brockow, K ;
D'Ambrosio, C ;
Kirshenbaum, AS ;
Ma, YS ;
Longley, BJ ;
Metcalfe, DD .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) :686-692
[3]   3 Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro [J].
Alessi, DR ;
Kozlowski, MT ;
Weng, QP ;
Morrice, N ;
Avruch, J .
CURRENT BIOLOGY, 1998, 8 (02) :69-81
[4]   Mutational analysis of the tyrosine kinome in colorectal cancers [J].
Bardelli, A ;
Parsons, DW ;
Silliman, N ;
Ptak, J ;
Szabo, S ;
Saha, S ;
Markowitz, S ;
Willson, JKV ;
Parmigiani, G ;
Kinzler, KW ;
Vogelstein, B ;
Velculescu, VE .
SCIENCE, 2003, 300 (5621) :949-949
[5]   Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling [J].
Bayle, J ;
Letard, B ;
Frank, R ;
Dubreuil, P ;
De Sepulveda, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12249-12259
[6]  
Beghini A, 2004, HAEMATOLOGICA, V89, P920
[7]   An MLCK-dependent window in late G1 controls S phase entry of proliferating rodent hepatocytes via ERK-p70S6K pathway [J].
Bessard, Anne ;
Coutant, Alexandre ;
Rescan, Claude ;
Ezan, Frederic ;
Fremin, Christophe ;
Courselaud, Brice ;
Ilyin, Gennady ;
Baffet, Georges .
HEPATOLOGY, 2006, 44 (01) :152-163
[8]  
Brizzi MF, 1996, J BIOL CHEM, V271, P3562
[9]   Prognostic impact of c-KIT mutations in core binding factor leukemas:: an Italian retrospective study [J].
Cairoli, R ;
Beghini, A ;
Grillo, G ;
Nadali, G ;
Elice, F ;
Ripamonti, CB ;
Colapietro, P ;
Nichelatti, M ;
Pezzetti, L ;
Lunghi, M ;
Cuneo, A ;
Viola, A ;
Ferrara, F ;
Lazzarino, M ;
Rodeghiero, F ;
Pizzolo, G ;
Larizza, L ;
Morra, E .
BLOOD, 2006, 107 (09) :3463-3468
[10]   Signal transduction by several KIT juxtamembrane domain mutations [J].
Casteran, N ;
De Sepulveda, P ;
Beslu, N ;
Aoubala, M ;
Letard, S ;
Lecocq, E ;
Rottapel, R ;
Dubreuil, P .
ONCOGENE, 2003, 22 (30) :4710-4722